Table V.

Comparisons of MRD at 12 weeks between relapse and non-relapse group with B-ALL.

			MRD at 12 weeks
Items	CR	Non-CR	<10−4	10−4−10−3	10−3−10−2	≥10−2
Relapse group	68	12	24 (30%)	29 (36.3%)	18 (22.5%)	9 (11.2%)
Non-relapse group	233	77	162 (52.3%)	102 (32.9%)	25 (8.1%)	21 (6.7%)
P-value	P>0.05		0.032	0.546	0.001	0.002